StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.1
  1. Startseite
  2. /Verbindung

Enoxacin

HCID 3229
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
74011-58-8
Standard-SMILES
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21
InChIKey
IDYZIJYBMGIQMJ-UHFFFAOYSA-N
Summenformel
C15H17FN4O3
Durchschnittliche Molmasse
320,32 g/mol
Monoisotopische Masse
320,12846862

Überblick

Enoxacin is a 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea. It has a role as an antibacterial drug and a DNA synthesis inhibitor. It is a monocarboxylic acid, an amino acid, a N-arylpiperazine, a 1,8-naphthyridine derivative, a quinolone antibiotic and a fluoroquinolone antibiotic.

Namen und Bezeichner

Bevorzugter Name
Enoxacin
IUPAC
1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid
Englischer Name
Enoxacin
Summenformel
C15H17FN4O3
Molmasse
320.32

Namen und Synonyme

enoxacin74011-58-8PenetrexEnoxacine1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acidFlumarkComprecinEnoxacinoAT-2266EnoxacinumCI-9191-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
Weitere Namen anzeigen
1-ETHYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-[1-PIPERAZINYL]-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACIDENXci919enoramAbenoxEnoxenEnoxorHumark
PD 1077791-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acidPD-107779CI 919DTXSID5022984NSC-629661NSC-758416CHEBI:157175

Datenbank-Bezeichner

CAS
74011-58-8
PubChem CID
3229

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
-0,2
Polarare Oberfläche (TPSA)
85,8 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
8
Frei drehbare Bindungen
3
Schwere Atome
23
Formalladung
0
Komplexität
521

Experimentelle und physikochemische Eigenschaften

Drugs · 4 Einträge

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals

Pharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use

LogP2.3
Solubility1.09e+00 g/L
Human Drugs · 3 Einträge

Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Quinolones; Fluoroquinolones

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Melting Point · 2 Einträge

220-224 °C

220 - 224 °C

Physical DescriptionSolid
Collision Cross Section · 2 Einträge

184.7 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

185 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS ClassificationNot Classified

Gefahrenhinweise

Hazard Classes and CategoriesNot Classified

Toxikologische Informationen

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Sicherheitsdaten

wgk
2
hs_code
29335995
RTECS-Nr.
QN2800000
risk_code
36/37/38
Toxizität
LD50 in male, female mice, male, female rats (mg/kg): 327, 391, 236, 294 i.v.; 1237, 1320, >2000, >2000 s.c.; all >5000 orally (Senda)
hazard_code
Xi
safety_code
26-36/37

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

Protein BindingEnoxacin is approximately 40% bound to plasma proteins in healthy subjects and is approximately 14% bound to plasma proteins in patients with impaired renal function.
Pharmacodynamics · 1 Eintrag

Enoxacin is a quinolone/fluoroquinolone antibiotic. Enoxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Enoxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. Enoxacin may be active against pathogens resistant to drugs that act by different mechanisms.

Mechanism of ActionEnoxacin exerts its bactericidal action via the inhibition of the essential bacterial enzyme DNA gyrase (DNA Topoisomerase II).
Biological Half-LifePlasma half-life is 3 to 6 hours.
Metabolism/MetabolitesHepatic. Some isozymes of the cytochrome P-450 hepatic microsomal enzyme system are inhibited by enoxacin. After a single dose, greater than 40% was recovered in urine by 48 hours as unchanged drug.
MeSH Pharmacological Classification · 3 Einträge

Substances that inhibit the growth or reproduction of BACTERIA.

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP1A2.

Absorption, Distribution and Excretion

Zugehörige Reaktionen

7
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 223155
HRID 223155als Eduktuspto-grants-1982_10
Reaktionsgleichung von HRID 325612
HRID 325612als Produktuspto-grants-1984_04
Reaktionsgleichung von HRID 325614
HRID 325614als Eduktuspto-grants-1984_04
Reaktionsgleichung von HRID 373327
HRID 373327als Produktuspto-grants-1992_11
Reaktionsgleichung von HRID 467280
HRID 467280als Produktuspto-grants-1992_10
Reaktionsgleichung von HRID 1215155
HRID 1215155als EduktTraining data from https://doi.org/10.1039/C8SC04228D (5/10)
Reaktionsgleichung von HRID 2198810
HRID 2198810als Eduktuspto-grants-1982_11

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
DTXSID
DTXSID5022984
ChEMBL
CHEMBL826
ChEBI
CHEBI:157175
UNII
325OGW249P
EC Number
961-175-5
Nikkaji
J20.568K

Physikochemische Eigenschaften

Schmelzpunkt
220 · 220-224 C
Siedepunkt
569.9 · 569.9±50.0 °C(Predicted)
Dichte
1.2931 · 1.2931 (estimate)
storage temp.
2 · 2-8°C
Löslichkeit
DMSO (Slightly), Methanol (Slightly)
pka
6.04 · 6.04±0.70(Predicted)
Aggregatzustand
Solid
Farbe
Off-White to Pale Yellow
Wasserlöslichkeit
50 mg/ml · 50 mg/ml in 1 M NaOHSlightly soluble in sodium hydroxide, dimethyl sulfoxide, chloroform and methanol. Insoluble in water.
InChI
InChI=1S/C15H17FN4O3/c1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20/h7-8,17H,2-6H2,1H3,(H,22,23)
InChIKey
IDYZIJYBMGIQMJ-UHFFFAOYSA-N
SMILES
N1(CC)C2C(=CC(F)=C(N3CCNCC3)N=2)C(=O)C(C(O)=O)=C1
CAS Datenbank
74011 · 74011-58-8(CAS DataBase Reference)
Rapidly absorbed following oral administration, with an absolute oral bioavailability of approximately 90%.
Cellular LocationsCytoplasm

Verwendung und Herstellung

UsesUse (kg; approx.) in Germany (2009): >100
Anwendungen · 2 Einträge

BeschreibungEnoxacin is a broad spectrum, quinolone-class, antibacterial agent closely related structurally to nalidixic acid. The serum half-life (6.2 hrs.) and urinary recovery (70%) are considerably greater than for other newer agents of this class, such as norfloxacin (10) and earlier mentioned ciprofloxacin.

VerwendenEnoxacin is an antibacterial agent used in the treatment of gastro enteritis including infectious diarrhea, respiratory tract infections, gonorrhea and urinary tract infections. It is a bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

(3alpha)-3-chloro-Cholest-4-eneNicotinamidEthylpropionatToluolTrichlormethanAcetyl piperazineTetrachlor-p-benzochinonDiethylmalonatEthylpiperazin-1-carboxylat2,6-Dichlor-3-nitropyridinFluoroboric acid2-BromethanolMethansulfonsurePalladiumdihydroxidDiethylethoxymethylenmalonatEssigsäureanhydridIsopentylnitrit
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 p sition. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.